AGIO — AGIOS PHARMACEUTICALS, INC.Today's name, from the SEC's present-day ticker list — a present-day mapping, not the name as of each filing.

Congress trades
8
all time
Members · 12m
1
3 buys · 0 sells · by trade date
Latest filing
09-10
2026-09-10
Rows filed past the STOCK Act's 45-day window, stated on the row, never editorialised; both dates and the receipt stay on every row.
0
every row filed inside 45 days
13F holders
—
issuer resolved · no holder rows
Congress: statutory ranges, filed up to 45 days after the trade · 13F: quarter-end snapshots, filed up to 45 days lateras of 2026-10-29

On Signals

ACTIVE HITS NAMING AGIO · NEWEST FILED FIRST · EVERY HIT CARRIES ITS RECEIPTSignals ↗
Active signal hits naming AGIO, newest filed first
KindWhoTraded → FiledSizeSrc
a disclosed trade in an issuer whose sector falls within a committee the member sat on as of the trade date (versioned mapping; membership dated) — context only: no legal, ethical, or causal conflict is established or impliedCisnerosTraded → Filed +21d$1.0K–$15.0K

1–1 of 1 line · 1 hit · each kind word opens its exact rule · every hit is in signals.v1.json.

COMMITTEE: Context, not an allegation.

Congress 8Institutional

Congress · disclosure timeline

By trade date · 24 months · 5 rows ▲ buy, ▼ sell; height = lower bound (log scale); ringed = on Signals. Trade date, not filing date — the filing lag is in the table below.

5 dated disclosures in the window, placed by trade date; magnitudes are the disclosed lower bounds, against gridlines at $15K, $250K, $5M; 1 ringed mark is a line of the Signals row above, pinned in the table below.

Members active in AGIO

12 months · most active first Rows = number of disclosures, not dollars. Net = lower bound of the net range. Committees as of each member's latest trade in the window (roster snapshot 2026-10-29).
Members disclosing AGIO in the trailing 12 months
MemberRowsNet disclosed flow for this ticker: purchases minus sales, computed as a net range on the disclosed amounts. A lower bound is provable, never a point.Number of committees the member sat on as of their latest trade date in the window, from the cc0-legislators roster snapshot. Context, never an allegation; jurisdiction overlap needs the sector join.
Gilbert Ray Cisneros, Jr. D–CA-313$3.0K to $45.0K2

1 member

Congressional disclosures

Signals rows first, then newestAll 8 rows ↗
Latest congressional filings mentioning AGIO, the rows on Signals first
FiledMemberSide · OwnerTraded · LagAmountRange · FlagsSrc
2026-09-10Gilbert Ray Cisneros, Jr. D–CA-31 On SignalsBUYTraded 08-20 +21d$1K–$15K
2026-04-07Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 03-03 +35d$1K–$15K
2026-01-12Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 2025-12-11 +32d$1K–$15K
2025-05-06Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 04-17 +19d$1K–$15K
2025-02-11Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 01-29 +13d$1K–$15K
2024-02-15Josh Gottheimer D–NJ-5BUY JT (jointly owned)Traded 01-24 +22d$1K–$15K
2015-06-07Thomas MacArthur R–NJ-3SELL JT (jointly owned)Traded 05-27 +11d$1K–$15K
2015-04-11Thomas MacArthur R–NJ-3BUY JT (jointly owned)Traded 03-18 +24d$1K–$15K

Institutional holders · 13F

Mapped, but not in the published aggregate.

AGIO resolves to AGIOS PHARMACEUTICALS, INC. (CIK 1439222), but this build's aggregate holds no entity-keyed top-holder rows for it. AGIO on SEC EDGAR ↗

Crowding — not available in this build. The ticker resolves to AGIOS PHARMACEUTICALS, INC. (CIK 1439222), but this build's aggregate holds no entity-keyed holder rows for it — its 13F securities are provisional identities without a CUSIP→issuer bridge — so it cannot be ranked among tracked names.

Congress ↔ notable managers · AGIO

Congress · last 90 days

Buyers
1 Gilbert Ray Cisneros, Jr. D–CA-31 $1K–$15K
Sellers
0 — —

filed 2026-07-31 → 2026-10-29 · statutory ranges

Notable managers

Not available for AGIO: the reviewed 13F name-and-class mapping does not name this ticker yet, so no notable manager's holding of it can be read. how tickers are mapped ↗

Merged timeline of congressional filings and notable-manager moves on AGIO
DateWhoChangeSize
2026-09-10Gilbert Ray Cisneros, Jr. CongressBUY$1K–$15K

1 newest, by filing date · 13F rows are quarter-end snapshots, not trades

Congress vs filers

12 months
Congress net (rows)3 buy / 0 sell
Congress net ($ bound)$3.0K to $45.0K
Filersnot computedThe ticker resolves to AGIOS PHARMACEUTICALS, INC. (CIK 1439222), but this build's aggregate holds no entity-keyed holder rows for it — its 13F securities are provisional identities without a CUSIP→issuer bridge — so the filer side cannot be computed. Convergence and divergence are stated only when both sides are computed.